VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
The RCVS Disciplinary Committee has dismissed a case against a London-based veterinary surgeon, having found charges related to fraudulent registration not proved.
Miss Maria Becerra Parga was charged with fraudulently entering her name on the Register of Veterinary Surgeons, by submitting a registration application in 2005 that contained a forged certificate of good standing from the Distinguished Official Veterinary Association of Lugo, Spain.
The Committee said that, in order to conclude Miss Becerra Parga had acted dishonestly, it needed to be sure that when she submitted the certificate to the RCVS she knew it was not genuine.
Miss Becerra Parga admitted that she did not make any application for the certificate directly to the Lugo Association. She accepted that the certificate she supplied to the College (the number of which was genuine and corresponded to a male veterinary surgeon registered in Spain) was a forgery, and that it contained a reference to her degree, a statement of good conduct, and was dated before she had a need for it; however, she said, this had been given to her by a friend and veterinary colleague and she had understood that she had been given a temporary membership of the Lugo Association for the purpose of registering with the RCVS. She also said that she had left these arrangements to her colleague and assumed that the document she had been given was genuine.
Her colleague, called as a witness by the College, said that Miss Becerra Parga had admitted the fraud to her and she denied that she had given the certificate to Miss Becerra Parga. Her friend said that she gave no more than general guidance because she knew that Miss Becerra Parga would be guided by a UK company that would arrange for her registration with the RCVS and through which she would be employed. She thought it possible that she had told Ms Becerra Parga that she needed a letter of recommendation, but she was not sure.
After careful consideration, the Committee preferred the evidence of Miss Becerra Parga and found her account to be "consistent with her naivety, inexperience and trusting nature" and "was sure that she did not forge the document herself". It found that to the extent that Miss Becerra Parga read the certificate at all when given it, she obviously did not notice its date or significance. The Committee was not able to say who was responsible for forging the certificate.
The Committee also dismissed an argument RCVS Counsel put forward, that Miss Becerra Parga had neither offered nor made payment for the certificate, and that she had forged the certificate to avoid a payment. The Committee said it did not find it credible that a veterinary surgeon, in work with a supportive family, who obviously was easily able to obtain proof of her good character directly from the university if necessary, would have jeopardised her entire career by forging the document, let alone for a small financial advantage.
The Committee directed that the charges be dismissed.
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
Generally, veterinary practices may remain open, but there are national variations in what services should be offered and how, including the conditions under which remote prescribing can be used to help support a case.
Wales currently has the tightest ‘firebreak’ restrictions, meaning practices can only provide essential and urgent work until midnight on 8 November 2020, thereafter, returning to usual operations in line with Wales’ standard measures around workplace safety.
England and Northern Ireland are under national restrictions (4 Nov – 2 Dec, and 16 Oct – 12 Nov, respectively), meaning practices can provide treatment essential for maintaining animal health and welfare, along with non-urgent work providing that social distancing measures and safe working can be maintained.
Veterinary surgeons practising in these three countries may also choose to support a case remotely at an earlier stage, for example, through the remote prescribing of POM-Vs without first having conducted a physical examination.
Scotland remains the only country under regional tiered restrictions, meaning practices can continue to provide treatment whilst maintaining social distancing; however, before remote prescribing is offered, veterinary surgeons should first consider whether the animal can be brought under their care.
The full guidance and corresponding flowcharts should be consulted together and are available at www.rcvs.org.uk/covidfaq2and www.rcvs.org.uk/covidfaq4.
VetYogi’s new ‘VetYogi Collective’ offers an on-demand online hub of yoga, mental health and wellbeing sessions designed to meet the individual needs of vets, RVNs, practice managers, receptionists, students and paraprofessionals.
Subscription includes a monthly live yoga session and access to a library of content which includes yoga sessions lasting from minutes to over an hour.
There are also videos, and advice on guided meditation to help support wellbeing and manage stress.
Chloe says: “It’s important that everyone who has a need, has access to the type of wellbeing tools that they respond best to, so we have developed self-care sessions for all roles in the profession.
"If you have had a hard day or a stiff neck from working in theatre for hours, or are just feeling tense and unable to switch off, you need help there and then.
"The VetYogi Collective provides that support around the clock which we simply couldn’t deliver any other way.”
Individual subscriptions cost £12 per month.
Practices signing up their team are offered preferential rates and can use the VetYogi Collective badge on their materials to signal their commitment to supporting wellbeing.
collective.vetyogi.com
The new hospital, which is led by a large team of internationally-renowned Specialists, supported by residents, interns and registered veterinary nurses, will over time employ over 100 veterinary professionals.
CVS says the site will offer the latest technology and treatments in all small animal disciplines including: general surgery, orthopaedics, neurology and neurosurgery, internal medicine, ophthalmology, cardiology, dermatology, oncology and dentistry, as well as dedicated anaesthesia, analgesia, diagnostic imaging and intensive care departments.
There will be a multi-disciplinary approach, with a team around every patient, to ensure the best outcome for the animal.
CVS says BVS's oncology department, with its stereotactic linear accelerator for radiotherapy, will offer most advanced cancer treatment for cats and dogs in Europe.
The site also has the latest CT and MRI scanners and a separate feline unit.
On arrival, clients are taken to a special customer experience zone by a dedicated client liaison officer to ensure their pet is comfortable and they are fully informed about their procedure.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our advanced facilities and eminent colleagues will mean we can provide the best animal care to pet owners across the South West, and we have invested in cutting-edge technology to bring cancer treatment in pets to the next level.
"So we know that this site will become as a centre of excellence in the veterinary world.”
https://www.bristolvetspecialists.co.uk
Kit, who has served on Council as an elected member since 2013, is currently the Chair of the RCVS Finances & Resources Committee and has been RCVS Treasurer for the past three years.
He is also a member of a range of committees and project groups across the RCVS including: the Audit and Risk Committee; the PIC/ DC Liaison Committee; the Certification Subcommittee; the Estate Strategy Project Board; the RCVS Knowledge Board of Trustees; and the Advanced Practitioners Panel.
Since 2003 Kit has been working as an internist (he is an RCVS-recognised Specialist in Small Animal Medicine) in private referral practice. In 2006 he became a founding partner in a multidisciplinary referral centre that he saw grow from five to 65 members of staff within five years.
His interests include workforce issues, communicating the diverse clinical and non-clinical skills of veterinary surgeons to the general public and government, and facilitating life-long learning through achievable further professional qualifications and effective CPD.
Kit said: "It was a great honour to be elected as the next Junior Vice President by my fellow council members. I feel that I can make a positive contribution to the work that the RCVS is already undertaking in ensuring the veterinary team remains healthy and respected. In particular I am keen to look at how the RCVS can help find solutions to our workforce issues - improving retention as well as encouraging and facilitating vets and nurses back into the profession."
In addition to Kit being elected as JVP, the current holder of that office, Dr Mandisa Greene, was confirmed as President for 2020-21 and current President, Dr Niall Connell, was confirmed as Senior Vice-President for this period.
Professor Susan Dawson was voted in as RCVS Treasurer, and she will be formally invested in this role at Royal College Day on Friday, 10 July.
Professor David Argyle has been elected as Chair of Advancement of the Professions Committee for a second year, Dr Susan Paterson has been elected as Chair of Education Committee for her second year, and Dr Melissa Donald has been elected Chair of Standards Committee for her second year.
Kit and Melissa's positions are subject to their successful re-election in the 2020 RCVS Council Elections
More information on the RCVS Council and its members can be found on the RCVS website: https://www.rcvs.org.uk/who-we-are/rcvs-council.
Fabtek Solutions has announced the launch of Meditek, an activated carbon wound dressing which has been impregnated with silver to enhance its antibacterial qualities.
Joy Coutts from Fabtek Solutions said: "Meditek uses Zorflex which is a 100% pure activated carbon fibre. It has a huge surface area due to its microporous structure, and a permanent electrostatic charge that attracts bacteria towards it, where they are immobilised and retained. When removed from the substrate, the bacteria die, but the microscopic particulates of metallic silver accelerate the bacteria kill.
"Better still, Meditek carries no risk phases as it's non toxic and non invasive."
Joy added: "We are commercial members of the Vet Wound Library, an initiative designed to help promote modern wound care to veterinary professionals, it also means members can try our dressings for free."
According to Fabtek, Meditek has been tried and tested by vets and produced excellent results. The company's website also features some case studies which show the wound before and after the use of Meditek.
Dressings are available in 10cm x 10cm, and 15cm x 25cm sizes, which can be cut to fit. Prices start from £35 for a box of five.
For more information, see http://www.fabteksolutions.com/, email admin@fabteksolutions.com or call 07794094011.
The RCVS has published new guidance for veterinary surgeons on 24-hour emergency first aid and pain relief, providing greater definition of the professional and legal responsibilities of veterinary surgeons in the provision of emergency care, as well as owners' responsibilities for their animals.
Two sections of the supporting guidance to the Code of Professional Conduct have been updated - Chapter 2 'Veterinary care' and Chapter 3 '24-hour emergency first aid and pain relief' - placing a greater emphasis on owners' legal responsibilities for their animals while obligating veterinary surgeons to provide full details of their 24-hour emergency cover provision to clients.
Although veterinary surgeons are professionally obliged to take steps to provide 24-hour emergency first aid and pain relief, the new supporting guidance clarifies situations where delaying or declining attendance to an animal may be appropriate. It is hoped this will assist and empower vets to decline to attend an animal away from practice where they feel it is unnecessary or unsafe.
The changes are the culmination of an evidence-gathering process with both members of the profession and animal owners about each group's expectations around the provision of 24-hour emergency care.
This process began with a call for evidence at the end of 2013, which garnered some 656 pages of written evidence, as well as a petition on home visits with over 2,800 signatures. Following this, in March 2014 there was a three-day hearing in which 15 organisations and 10 individuals were invited to attend to give evidence to the RCVS Standards Committee. Also taken into account were more than 1,000 responses from veterinary surgeons taking part in the Survey of the Professions and an online survey with 1,250 animal owners.
After a thorough review of the evidence the Standards Committee developed the new supporting guidance, which was agreed in principle by RCVS Council in its June meeting.
Gordon Hockey, RCVS Registrar, said: "Following the considerable disquiet within the profession following the Disciplinary Committee's decision on the Chikosi hearing in June 2013, we decided that only a thorough evidence-gathering process with all parties could resolve the apparent gap between the expectation of the public regarding 24-hour emergency care and the profession's ability to meet this.
"We are very happy with the way that this process was carried out and would like to thank the many individual veterinary surgeons and animal owners, as well as representative organisations, who have contributed to this outcome.
"By making the legal and professional obligations of veterinary surgeons and the welfare obligations of animal owners clearer we hope that this new guidance should allay some of the frustrations and concerns of the profession."
The new supporting guidance for Chapter 3 '24-hour emergency first aid and pain relief' can be viewed at www.rcvs.org.uk/247care, while the additional guidance for Chapter 2 'Veterinary care' can be viewed at www.rcvs.org.uk/vetcare
A webinar in which Gordon Hockey and Clare Tapsfield-Wright, former Chairman of Standards Committee, explain the guidance in greater detail takes place at 8.30pm tonight.
Visit www.thewebinarvet.com/rcvs to register.
The RCVS has announced that it will start to accept the first applications for the new Advanced Practitioner status from the start of September.
The new accreditation status represents a 'middle tier' between veterinary surgeons holding an initial veterinary degree and RCVS Specialists and will demonstrate that the veterinary surgeon has advanced knowledge and experience in a designated field of veterinary practice.
Practising veterinary surgeons with at least five years' experience and a relevant postgraduate qualification are eligible to apply to be recognised as RCVS Advanced Practitioners. Accepted qualifications include the Certificate in Advanced Veterinary Practice (CertAVP) with a designation; the RCVS Certificate awarded up to 2012; postgraduate clinical qualifications awarded by universities or recognised awarding bodies; and other relevant clinical postgraduate master's degrees. Full details of eligible qualifications can be found at www.rcvs.org.uk/advanced
Advanced Practitioners will be expected to undertake at least 250 hours of continuing professional development (CPD) over each five-year period of accreditation, of which 125 hours should be in their designated field.
Dr Kit Sturgess is Chair of the Advanced Practitioner Assessors Panel and was involved in the development of the scheme. He said: "I am very proud that we will soon be accepting applications for the Advanced Practitioner status, just two years after the need for such an accreditation was highlighted by Professor Sir Kenneth Calman's Specialisation Working Party, set up to look at the whole specialisation framework.
"Being an Advanced Practitioner is more than just a status - it will demonstrate to members of the public and colleagues alike that a veterinary surgeon is working at an advanced level in their field and has made an ongoing commitment to career development and lifelong learning through engaging with CPD over and above the RCVS minimum requirement."
Applications from holders of the RCVS Certificate in Advanced Veterinary Practice (CertAVP) with a designation can apply from 1 September 2014 while those holding any other relevant qualifications can apply from 13 October 2014. The deadline for all applications during this first round is 30 November 2014.
Applications can be made online at www.rcvs.org.uk/advanced where further information about eligible qualifications, CPD requirements and other details can be found. The application fee for this year is £50 - from next year it will be £80. Thereafter there will be an annual fee to remain on the list (£80 by direct debit; £90 otherwise, at current rates).
All eligible applications will be assessed by the Advanced Practitioner Assessors Panel. The first list of Advanced Practitioners is due to be published, alongside the updated Specialist list, in spring 2015 subject to approval by the RCVS Education Committee in February 2015.
If accepted on to the list, practitioners will be able to use 'RCVS Advanced Practitioner in [designated field]' after their names. The accreditation and its designation will also be a primary search field on the RCVS Find a Vet practice database as well as appearing after an individual's name on the Check the Register search tool.
Once the first list has been published, the status of Advanced Practitioner will be promoted to the public.
A free webinar about Advanced Practitioner status, hosted by the Webinar Vet, will take place on Tuesday 30 September at 8.30pm. To register for the webinar visit www.thewebinarvet.com/rcvs-advanced-practitioner-status
For further advice or details about making an application for Advanced Practitioner accreditation, visit www.rcvs.org.uk/advanced or contact the Education Department on 020 7202 0791 or ap@rcvs.org.uk
Defra's new measures include:
Eleven additional licences for badger control covering parts of Devon, Wiltshire, Somerset, Dorset and Cheshire. Licences have been granted for supplementary badger control in areas of Gloucestershire and Somerset which have completed their original four-year licences.
The relaunch of the Badger Edge Vaccination Scheme following suspension due to a global shortage of TB vaccine, with groups invited to submit expressions of interest and feedback on the criteria for the scheme.
A new bTB Advisory Service for farmers to provide advice on-farm and by phone or email to farmers in High Risk and Edge Areas on bTB biosecurity and risk-based trading, set to launch this autumn.
Tighter control of Inconclusive Reactors (IRs) in the High Risk and Edge Area, to come into force from 1 November.
British Veterinary Association (BVA) President Gudrun Ravetz said: "Today’s announcement sees 11 new licences issued and, while BVA supports badger culling as part of a comprehensive strategy for tackling bovine TB, we will continue to call on the Government to use the targeted and humane method of cage trapping and shooting only - rather than the current method of controlled shooting.
"As one of the many tools in the toolbox, we welcome the re-commencement of the Badger Edge Vaccination Scheme, particularly if used as a ‘firebreak’ to mitigate the spread of the disease into the low risk areas. The introduction of a TB Advisory Service will provide valuable additional support for farmers, who we’d encourage to continue working with local vets on biosecurity and herd health planning.
"Yet we are concerned that Government policy seems to have moved away from the original, evidence-based proposal of a six-week time limit for badger control within the open season, which enables an intensive, coordinated and effective operation in order to secure optimum disease control benefits.
"In terms of numbers, it is clear that badger population estimates have previously demonstrated considerable uncertainty and imprecision. It is critical that as accurate as possible population estimates, using an evidence-based methodology, are obtained and made openly available.
"We would urge clarity over cull timeframes, numbers and mid-cull review methodology to ensure that the progress made, enabling the application for Officially TB Free status, is not undermined."
Today’s Defra update follows a consultation on licensed badger control conducted at the start of 2017, to which the British Veterinary Association (BVA), British Veterinary Zoological Society (BVZS) and the Association of Government Veterinarians (AGV) submitted a formal, joint response.
Photo: Young Eurasian Badger (Meles Meles), by BadgerHero, CC BY-SA 3.0
Andy, who was previously the Junior Vice Chair of the association, has been a member of BVOA for over 25 years, during which time he's been instrumental in organising scientific meetings and starting the popular BVOA discussion forum.
He is an RCVS and ECVS Specialist and in 2017 was made a Fellow of the RCVS for meritorious contributions to clinical practice.
He has taught numerous surgical residents and is widely published in many areas of orthopaedic surgery.
In 2023 he opened the Moores Orthopaedic Clinic, a dedicated orthopaedic-only referral clinic near Basingstoke in Hampshire.
Andy said: “It’s a great honour to take on the role of chairman for an organisation that I am so fond of.
“I am passionate about education and have taught, lectured and published widely.
"In my role at the Moores Orthopaedic Clinic I am always happy to discuss cases and assist colleagues as much as possible.
"I truly believe sharing knowledge is essential to successful patient outcomes, and BVOA allows this in numerous ways.
"My thanks go out to the rest of the BVOA committee for continuing to ensure we have a strong and vibrant Association, especially to Mark Bush my predecessor and to Sarah Girling who has left the committee this year after serving as Senior Vice Chair.”
All veterinary professionals with an interest in orthopaedics are welcomed and encouraged to join BVOA.
https://bvoa.co.uk/
The grants, which are for up to £3,500 per annum, are for students embarking on a gateway or main veterinary degree course, possibly as a second degree.
Amber Cordice was an early recipient of a Quadstar Foundation grant which she has had for the last four years.
She'd always wanted to be a vet, but didn't quite get the A level grades, so she took an undergraduate Zoology degree and got a first.
She was then awarded a place at Harper and Keele Veterinary School, but just didn't have the money because there is no finance for second degrees.
So the enterprising student set up a 'Go Fund Me Page' which got reported by VetSurgeon.org News, which is how Nick found out about her challenges and the rest is history.
Except not quite, because then Alicia Guarnieri (pictured) found herself in a similar position.
She'd completed a degree in Bioveterinary Science before starting a vet degree at the University of Bristol.
She said: “I’d managed to save up prior to being offered my place but when Covid hit, most of it went on rent.
"Like Amber, I decided to defer my place. I looked everywhere for grants, spending hours sifting through guides and asking all the vets I knew, but it all came to a dead end."
But then she came across Amber's story on VetSurgeon.org and, through her, found out about the Quadstar Foundation which awarded her with a grant which covers over a third of her tuition costs.
Alicia added: “Finances are a huge barrier to students taking a second degree, particularly after tuition fees increased.
"There are many of us in the same boat, and sadly many who turn down their place solely due to cost.
"Nick and the Quadstar Foundation are truly changing people’s lives by offering this support.
"Having thought I would never get to this point, I can’t wait to qualify next year and finally become a vet, and I am forever grateful for the help The Quadstar Foundation has provided me.”
Quadstar's latest grantee is Raluca Magadan, a veterinary nurse from Ireland, who is now on the accelerated graduate course at Bristol University.
She said: “Doing a second degree was never going to be easy.
"However, through help from family and locum vet nurse work, I managed to afford my first three years of vet school and made it into final year.
"This is where the difficulty came, as I had to more than forty hours per week of unpaid rotations work, plus clinical EMS during the holiday breaks, which made it very hard for me to earn the money I needed to afford my final year.
"At times it meant I had under £100 to survive an entire month on, which became a big physical and mental challenge.
“That’s when the Quadstar Foundation stepped in and took a weight off my shoulders by helping to pay off my outstanding university fees and providing some financial security in my final months.
"This has been a huge relief and allowed me to finally enjoy my last year at Bristol.
"I can’t thank everyone at the charity enough.”
In addition to funding and mentoring, The Quadstar Foundation helps its grantees with everything from job applications to revision techniques, as well as any mental health crises and helping them to find a place to live.
Nick, who also runs a property and acquisitions company and Animus Surgical, a pet and vet supplies company, said: “Having worked as a vet for many years before setting up my businesses, I have great industry connections and knowledge.
"So, I’m in the privileged position of being able to help committed students to seize the career opportunities they deserve.”
“My main commercial motivation now is to be able to maintain the funding streams required for these grants.
"It’s surprisingly hard to fundraise for individuals.
"That’s why Animus Surgical has just committed to donating 15% of its profits to the Quadstar Foundation.”
He added: “It’s an enormous privilege to support these inspiring young vets who have had such a hard slog to get past the ever-increasing barriers they face. Barriers that back in our day didn’t exist.”
What a lovely story. VetSurgeon.org is proud to have played a tiny little part in it and wishes Amber, Alicia and Raluca every success in their future careers. And hats off to Nick.
www.quadstar.org
The refreshed packaging keeps the same colour scheme, but the graphics indicating the product uses stand out better.
The company has also added an area on the side of the carton for owners to note the date each dose is given.
What can I say, it's a slow news day.
Francesca's initiative was recognised with a RCVS Knowledge ‘Highly Commended’ status at its 2024 awards.
The idea for the audit came about after Francesca noticed a trend for patients to become hypotensive during anaesthesia for routine feline neutering and need additional treatment.
CVS says clinical evidence suggests a minimum value of 60mmHg for perfusion of vital organs such as the brain, heart and kidneys.
So a clinical audit was undertaken to look at perioperative blood pressure in both cats and dogs having routine neutering procedures.
The target was for patients to maintain a mean arterial blood pressure of 60mmHg during their anaesthetic.
The animals chosen for auditing were to be classed ASA 1 and under 5 years old.
They received a pre-operative health check including a blood pressure reading to ensure they were normotensive.
A first audit looked at a standard premedication protocol of ACP at a dose rate of 0.02mg/kg combined with methadone at a dose rate of 0.3mg/kg.
A second audit initiated a change to the pre-medication drugs, using 0.005mg/kg medetomidine combined with the same dose of methadone.
Both received anaesthesia induction with Propoflo at a dose rate of 6mg/kg for cats and 4mg/kg for dogs.
All patients under anaesthetic were maintained using isoflurane and kept at a surgical plane of anaesthesia appropriate for that patient.
The patients were monitored throughout their surgical procedure using an oscilliometric monitoring machine - for systolic, diastolic and mean arterial blood pressure – and measurements recorded on an anaesthetic chart.
The collected data revealed that in the first audit, where patients received ACP and methadone, 42% (50% of cats and 38% of dogs) had a mean arterial blood pressure lower than 60mmHg after the first five blood pressure readings post induction.
In the second audit, with medetomidine combined with methadone, only 11% of patients (0% of cats and 15% of dogs) with a mean arterial blood pressure lower than 60mmHg.
In addition to the reduction in hypotensive patients during anaesthesia when the medetomidine/methadone combo was used, Francesca says the audit suggests a link to hypotension with ACP used as a premedication in anaesthetised patients.
Francesca said: “My passion in veterinary nursing is anaesthesia. And there is always room for improvement and striving to achieve gold standard care.
“These results clearly show that a change from our current premedication protocol of ACP and Methodone to Medetomidine and Methadone decreased the number of patients having hypotension during anaesthesia. The change means fewer patients were at risk of developing the side effects associated with hypoperfusion of the vital organs.
“Our quality improvement initiative has made a really positive impact in practice for both patient care and clinical team.”
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
The Fédération Équestre Internationale (FEI) has added Metacam for Horses to its 'list of detection times'.
According to the manufacturer, Boehringher Ingelheim Vetmedica, Metacam (meloxicam) is the first preferential COX-2 inhibitor to be added to this list, and has stated plasma and urine detection times of 72 hours administered intravenously or orally1. This is the shortest urine detection time of the NSAIDs available for use in horses, and compares to the 168-hour (7 days) detection time for phenylbutazone stated by the FEI.
Craig Beck, equine sales and marketing manager for Boehringer Ingelheim in the UK and Ireland said: "We have been very happy to work in partnership with the FEI to provide the robust data that has supported the FEI in their analysis of Metacam. Metacam is an important addition to the FEI list, that will help vets treating competition horses. There is now a modern and proven NSAID which extends the therapeutic options available to vets."
Metacam is licensed in horses for the alleviation of inflammation and relief of pain associated with musculo-skeletal disorders or colic.
For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
1 Detection Time agreed with the European Horse Racing Scientific Liaison Committee (EHSLC)
Britain's dairy industry is doomed unless it takes more effective steps to control the spread of endemic diseases like tuberculosis and bovine virus diarrhoea, according to a leading cattle vet.
At a conference on infectious disease at the Royal Veterinary College last week, Devon practitioner Dick Sibley warned that the management and economic trends in the UK dairy industry are increasing the risk of disease transmission - and its potential impact once it does enter a herd.
Figures he obtained from the British Cattle Movements Service show that about four million cattle, or half the total UK cattle herd, are moved from one premises to another each year. Those being sent for slaughter were unlikely to spread infections but moving cattle of unknown disease status to new premises greatly increased the risk of bringing in new diseases. "If you set out to design a system that guarantees that we will continue to have problems with endemic disease then I could not think of a better one than this," he said.
Cattle numbers are increasing in those areas like Devon and Cheshire which already have among the highest population densities for dairy animals in the world - and are also the main hot spots in the current bovine TB epidemic. Farmers feel compelled to buy in heifers from as far afield as Germany and Holland to replace animals culled as TB reactors, as they will lose bonus payments from customers who demand that they maintain constant levels of production.
Several other factors also increase the likely impact of disease in a previously healthy herd - the concentration of cattle numbers into fewer but larger units, the growing emphasis on cattle kept indoors all year round and breeding for high yielding animals that are more vulnerable to disease. Meanwhile, a shortage of skilled manpower means that half the available stockmen are shared between farms and can therefore be responsible for bringing in disease.
But farmers have little or no control over some of the more important risk factors - particularly movements of badgers and the presence of diseased herds on neighbouring premises. "So these farmers with big herds in high density areas and neighbours that have the disease are done for unless we can do something serious to manage the risks."
Dairy farmers can work with their veterinary advisers to reduce risk using the four main pillars of disease control - improved biosecurity, better surveillance, appropriate vaccination and containment of disease transmission within the herd. But diseases also had to be tackled on a national level and if DEFRA is unwilling to take on the task, he proposed the creation of an independent livestock disease agency with sufficient staff and resources to carry out its remit. The costs of running such a body should be shared among all those stakeholders with an interest in preserving an economically viable dairy industry, including, for example the cereal producers who provide the dairy industry with much of its food materials, he suggested.
Vet History is part of a five year project to improve access to and awareness of the wealth of material held by the College, which began with the appointment of a qualified archivist in October 2015 and the creation of the online database which includes descriptions of material catalogued to international archive standards. The catalogue will be fully searchable with biographical profiles for major persons featured in the collections.
The papers of the prolific veterinary author and army veterinarian Major General Sir Frederick Smith (1857-1929) are amongst the first collections to be fully catalogued and described online. The material covers the length of Smith’s career from case notes recording treatment of army horses in India in the 1880s to correspondence from the last 20 years of his life, in which he wrote a four volume history of veterinary literature. Smith was involved in the Army Veterinary Service during the Second Anglo-Boer War and the First World War, and his honest and candid accounts of the loss of horses by the Army illustrate fascinating aspects of veterinary, social and military history.
Chris Gush, Executive Director, RCVS Knowledge said: "The launch of the Archives catalogue covers a critical and fascinating time in the nation’s history, both for the advances in veterinary science and its role in marinating a functioning British military presence in the 19th century. Through this unparalleled collection, RCVS Knowledge can be an invaluable source of information for academic research and the general public."
The RCVS Vet History project is ongoing, and further collections will be catalogued periodically over the next four years. Visitors are encouraged to check the catalogue regularly, and follow RCVS Knowledge’s Twitter feed for news and updates.
To see behind the scenes of the Project, and find out more about highlighted items, follow the Historical Collections blog here.
The RCVS Vet History Project is supported by The ALBORADA Trust.
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
Avacta has announced the launch of Sensitest, the only UK-specific equine allergy tests that use non-invasive procedures.
The company says that the new range of ELISA tests was developed using native plant allergen species, to reflect the needs of UK and Northern European veterinary surgeons.
Janice Hogg, Avacta senior veterinary director, said: "In the development trials, allergens were selected that showed significant levels of reactivity in horses with clinical signs compatible with allergic disease.
"Whilst many providers of allergy tests are reducing the number of allergens in their panels and providing only a global range of allergens, this research has shown it is vital to include native species of allergenic plants and insects.
"The new ELISA test, which includes allergens such as orchard grass, daisy, dandelion, nettle and horse chestnut, provides UK practitioners with a viable alternative to intradermal testing (IDT). It doesn’t require clipping and has no adverse reactions - ideal for clients who want to avoid this."
Avacta says Sensitest includes panels of allergens that cover the work up of food, respiratory and atopic allergic disease assisting in a more accurate diagnosis, treatment and management options, including allergen-specific immunotherapy.
Janice added: "It is not necessary to withdraw medications (except high dose corticosteroids) for the standardised procedure, which has excellent reproducibility and is not influenced by existing skin pathologies, all of which is really useful when working with equine clients.
"To further assist equine practitioners, especially those faced with non-insured clients, the SENSITEST Equine Screening Test offers a simple positive/negative result to each panel, allowing expansion to the full panels as required to assist with treatment."
For more information contact your Avacta area territory manager, call customer services on 0800 8494 550 or visit www.avactaanimalhealth.com/equineallergy
The Veterinary Wound Healing Association (VWHA) has become the third veterinary association to make a new home on VetSurgeon.org.
VWHA President Jacintha Wilmink said: "We're very excited about joining VetSurgeon.org and how it will allow our members to connect with each other and share information quicker and more easily than ever before".
In common with the other associations, the VWHA is making its content available for all VetSurgeon members to access, however only VWHA members can submit cases to its section for discussion, or participate in the VWHA forum. Jacintha added: "We hope that the cases and discussions in our section of the site will be of value to all practitioners, and that many more of you will want to join the association and participate".
Information about the benefits of joining the VWHA is available here.
The initiative was first launched in 2018 as a small-scale pilot.
Following a hiatus during Covid, and subsequent adaptations and expansion, the 2022 programme saw 12 new graduate vets from PDSA and 22 from Vets Now take part.
Dr Aoife Reid, Head of Edge programmes and Clinical Career Progression at Vets Now said: “We recognised that within ECC practice, surgical cases are less common.
“When they do happen, though, they are high-stakes and are usually lifesaving.
"So, it’s important to maintain the surgical skills of our veterinary surgeons.”
Meanwhile, while each of PDSA Pet Hospital’s perform hundreds of surgical procedures every week, working in collaboration with Vets Now’s 60-plus clinics and hospitals gives new graduates exposure to more intensive and time-critical emergencies.
They encountered case presentations that are more commonly seen in emergency situations, including dystocia, seizures and dyspnoea; and developed their skills utilising point of care ultrasound and blood gas analysis with more critical patients.
Gemma Renwick, PDSA Area Veterinary Manager said: “This a scheme has really positive mutual benefits and provides a greater level of understanding of how each other works.
“It makes for a smooth transition between the day and the night service; which results in a much better experience for both clients and pets.”
Before attending, vets get a taster of what to expect through short webinar-style videos. They each then spend three shifts working alongside the other veterinary teams.
The Vets Now clinicians perform several surgeries in one shift, something that would rarely happen in all but the busiest of emergency clinics.
They also benefit from discussing cases when they may be more used to working in a solo environment and receive feedback from an experienced PDSA Clinical Coach.
Vets Now says feedback from both sides has been hugely positive, with participating vets saying they felt welcomed and supported.
Aoife said: “Within the veterinary industry, although it’s a small and close-knit community, we rarely see organisations collaborating in this way.“
"So, it’s great to work together to help benefit both our vets and the clients.”
The session will provide a practical guide to dealing with various emergencies that may present to vets and nurses across multiple disciplines.
The full schedule includes:
Arlene Connor, Interim Hospital Director at Hamilton Specialist Referrals, said: “Being presented with an emergency patient can be an intense and high-pressure situation, and it’s one that all vet professionals should do their best to prepare for so they are comfortable making decisions under pressure.
"We have a brilliant team here at Hamilton Specialist Referrals, all of whom are well equipped and very experienced when it comes to dealing with emergencies and this is an unrivalled opportunity to learn from them.”
Tickets cost £80+vat, including lunch and refreshments
https://www.eventbrite.co.uk/e/the-emergency-patient-tickets-861637851007
www.hamiltonspecialists.vet
Virbac is running a promotion through which practices can claim a model showing the anatomy of a healthy dog ear canal on one side, and the changes associated with chronic damage on the other.
Product Manager Chris Geddes MRCVS said: "The models are about 15cm high and provide a useful visual aid to show clients the consequences if chronic ear disease is not kept under control. They can also be used to help show clients how to administer their pet's treatment correctly.
"These models will be a useful tool for practices to help improve client compliance. Also, we know that some dog owners find a course of ear treatments tricky, and either give the wrong dose or give up altogether, which is why we designed EasOtic to dispense the exact dose in one simple 'squirt', with one complete course in each bottle".
For details of how you can obtain a model for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.